Recent advances in the treatment of brain disorders have resulted in a notable decline in mortality rates. Although this is encouraging, the number of survivors at risk for seizures has consequently increased. Seizure management in acute clinical settings poses a significant challenge, particularly in patients who are unable to take oral medications because of impaired consciousness, perioperative conditions, or critical illnesses. Furthermore, acute symptomatic seizures are associated with an increased short-term mortality rate [1–3], highlighting the crucial need to both suppress and prevent seizures [4,5].
3
AGO
AGO
0